US Patent Issued to ARO Biotherapeutics on Dec. 9 for "EPCAM binding fibronectin type III domains" (Pennsylvania Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,255, issued on Dec. 9, was assigned to ARO Biotherapeutics Co. (Philadelphia).

"EPCAM binding fibronectin type III domains" was invented by Russell C. Addis (Philadelphia), Robert Kolakowski (Philadelphia), Swapnil Kulkarni (Philadelphia), Steven G. Nadler (Philadelphia), Karyn O'Neil (Philadelphia) and Yao Xin (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to polypeptides, such as fibronectin type III (FN3) domains that can bind EpCAM, their conjugates, isolated nucleotides encoding the molecules, vectors, host-cells, as well as methods of making and using the molecules."

The patent was filed on Oct. 14,...